Online citations, reference lists, and bibliographies.
← Back to Search

Albumin Nanoparticles For The Intravitreal Delivery Of Anticytomegaloviral Drugs.

J. M. Irache, M. Merodio, A. Arnedo, M. A. Camapanero, M. Mirshahi, S. Espuelas
Published 2005 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
Albumin nanoparticles (NP) were proved to be effective and safe carriers for delivering anticytomegaloviral compounds in the vitreous. NP improved the antiviral activity of both ganciclovir and the phosphodiester oligonucleotide analog to formivirsen. NP appeared to be fusogenic carriers able to target the nucleus of cells. In addition, these drug carriers were well tolerated when administered by the intravitreal route and did not induce autoimmune reactions.



This paper is referenced by
10.1586/eop.09.70
Drug delivery to the posterior segment of the eye for pharmacologic therapy
Shalin S Shah (2010)
Invasive Modalities in Ocular Drug Delivery : Emphasis on the Posterior Segment
Praneeth Kakullamarri (2017)
10.1007/s11095-008-9694-0
Recent Perspectives in Ocular Drug Delivery
Ripal Gaudana (2008)
10.2217/nnm-2018-0206
Chemosensitizer and docetaxel-loaded albumin nanoparticle: overcoming drug resistance and improving therapeutic efficacy.
Jagdish P Desale (2018)
10.5497/WJP.V2.I4.78
Drug delivery in ocular diseases: Barriers and strategies
Deep Kwatra (2013)
10.22159/IJPPS.2016V8I10.11295
DRUG-RESISTANT TUBERCULOSIS: RECENT APPROACH IN POLYMER BASED NANOMEDICINE
Jessy Shaji (2016)
10.1007/978-3-319-95807-1_7
Nano/Microparticles for Retina and Posterior Diseases
A. Patel (2018)
10.1016/j.sjopt.2014.02.009
Nanocarriers of nanotechnology in retinal diseases.
A. Alhalafi (2014)
10.1016/j.vetpar.2011.05.028
Nanomedicine: novel approaches in human and veterinary therapeutics.
J. M. Irache (2011)
Recent Advances in Colloidal Systems and Gels for Posterior Ophthalmic Delivery
Kyle Villano (2017)
10.1097/IJG.0b013e31814b990d
Barriers to Glaucoma Drug Delivery
D. Ghate (2008)
Nanotechnology based drug delivery system(s) for the management of tuberculosis.
R. Pandey (2006)
10.1016/j.nano.2009.02.003
Nanomedicines for ocular NSAIDs: safety on drug delivery.
J. Araújo (2009)
10.1007/s11095-009-0042-9
New Techniques for Drug Delivery to the Posterior Eye Segment
E. Eljarrat-Binstock (2009)
10.1201/B15642-8
Nanotechnology Applications in Urology
Himanshu Aggarwal (2013)
10.1371/journal.pone.0028720
Intraocular Pressure Changes: An Important Determinant of the Biocompatibility of Intravitreous Implants
L. Zou (2011)
10.1007/978-981-10-2116-9
Albumin in Medicine
M. Otagiri (2016)
10.1007/978-3-319-47691-9
Ocular Drug Delivery: Advances, Challenges and Applications
Richard T. Addo (2016)
10.1016/j.biomaterials.2013.11.001
Enzyme delivery using the 30Kc19 protein and human serum albumin nanoparticles.
Hong Jai Lee (2014)
10.1016/j.colsurfb.2020.111286
Synergistic antitumor efficacy of doxorubicin and gambogic acid-encapsulated albumin nanocomposites.
Zhoujiang Chen (2020)
Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential.
Zahoor Ahmad (2006)
Catalytic Potential and Ligand Binding Properties of the Malachite Green RNA Aptamer
J. Costa (2008)
10.3109/9781420045154-21
Toxicity of nanoparticles in the eye
T. W. Prow (2007)
10.1080/03639040801926733
Evaluation of Arsenic Trioxide-Loaded Albumin Nanoparticles as Carriers: Preparation and Antitumor Efficacy
Zhiwen Yang (2008)
10.3390/ma11030394
Protein-Based Nanoparticle Preparation via Nanoprecipitation Method
Mohamad Tarhini (2018)
10.3109/10717544.2014.923065
Colloidal drug delivery system: amplify the ocular delivery
Ameeduzzafar (2016)
10.1016/J.JDDST.2019.04.042
In vitro characterization of new stabilizing albumin nanoparticles as a potential topical drug delivery system in the treatment of corneal neovascularization (CNV)
J. Llabot (2019)
10.1007/978-3-319-29346-2_18
Intraocular Drug Delivery Technologies: Advancing Treatment of Posterior Segment Disorders of the Eye
V. Pillay (2016)
10.1201/B15642-8
Book Chapter 7: Therapeutic Applications and Targeted Delivery of Nanomedicines and Nanopharmaceutical Products.
H. M. Mansour (2013)
10.1080/17425247.2016.1193149
Albumin nanostructures as advanced drug delivery systems
Mahdi Karimi (2016)
10.1016/J.IJPHARM.2006.11.028
Encapsulation of dexamethasone into biodegradable polymeric nanoparticles.
Carolina Gómez-Gaete (2007)
10.1016/j.preteyeres.2010.08.002
Applications of nanoparticles in ophthalmology
Y. Diebold (2010)
See more
Semantic Scholar Logo Some data provided by SemanticScholar